Regulatory
- Research & Development (R & D)
- Clinical Research
- SAS (Statistical Analysis System)
- Dossiers
- Pharmacovigilance
our documentation
explore our documentation
Quality Control
- Certificate of Analysis
- Analytical Testing
- Stability Studies
- chromatography
- Testing Method
GMP (Audit)
- Good Manufacturing Practices (GMP)
- Good Laboratory Practice (GLP)
- Quality Management System (QMS)
- Understanding of 21CFR
- ALCOA, ALCOA+, ALCOA++
Quality Assurance
- Corrective And Preventive Action (CAPA)
- Validation Protocol
- Drug Master File (DMF)
- Change Control
- Deviation Control
about us
Providing you with a seamless and reliable pharmaceutical documentation experience.
Setting new standards in pharmaceutical documentation excellence,
Modern & Friendly
We strive to deliver the best pharmaceutical documentation experience for you.
Professional
We are committed to delivering the highest standard of pharmaceutical documentation.
I Am Pharmacist
Pharmacist have main role in pharmaceuticals sector
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam lobortis laoreet ante, ut rutrum felis tincidunt vel. Proin tellus magna, malesuada sit amet justo non, interdum congue tortor. Donec volutpat sollicitudin urna consequat luctus.
ruth polina
sales associate
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam lobortis laoreet ante, ut rutrum felis tincidunt vel. Proin tellus magna, malesuada sit amet justo non, interdum congue tortor. Donec volutpat sollicitudin urna consequat luctus.
john wick
retail specialist
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam lobortis laoreet ante, ut rutrum felis tincidunt vel. Proin tellus magna, malesuada sit amet justo non, interdum congue tortor. Donec volutpat sollicitudin urna consequat luctus.
sophia james
studio executive
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam lobortis laoreet ante, ut rutrum felis tincidunt vel. Proin tellus magna, malesuada sit amet justo non, interdum congue tortor. Donec volutpat sollicitudin urna consequat luctus.
Liam Alexander
Business Analyst
news & blogs
our latest news & blogs
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin nisi elit, consequat pharetra elementum nec, eleifend non turpis.
-
Forced Degradation Study: Purpose, Design & Compliance
Learn forced degradation study design, stress conditions, stability-indicating methods, ICH requirements, and regulatory expectations. Definition Forced degradation studies are pharmaceutical stress-testing experiments that intentionally expose drug substances and drug products to extreme conditions such as heat, light, oxidation, humidity, and pH variations to identify degradation pathways, characterize impurities, and develop stability-indicating analytical methods required for…
-
Photostability Testing of Drug Products According to ICH Q1B
Learn ICH Q1B photostability testing requirements, light exposure limits, study design, packaging evaluation, and GMP compliance strategies. Definition Photostability testing according to ICH Q1B evaluates whether exposure to visible and ultraviolet light causes unacceptable changes in a drug substance or drug product. The guideline requires exposure to at least 1.2 × 10⁶ lux hours of…
-
Data Integrity in Stability Testing: ALCOA+ & GMP Guide
Learn ALCOA+ principles, GMP requirements, audit trails, and best practices for ensuring data integrity in pharmaceutical stability testing. Definition Data integrity in stability testing refers to the completeness, consistency, accuracy, and reliability of stability study data throughout its lifecycle. Pharmaceutical companies ensure data integrity through ALCOA+ principles, validated systems, audit trails, secure documentation practices, and…
-
Out-of-Trend (OOT) Results in Stability Studies: Investigation and CAPA
Learn how to identify, investigate, and manage Out-of-Trend (OOT) results in stability studies using CAPA, GMP principles, and risk-based approaches. Definition An Out-of-Trend (OOT) result in stability studies is a test result that remains within specification limits but deviates significantly from the expected historical trend or degradation pattern. OOT investigations help identify potential product quality…
-
Bracketing and Matrixing in Stability Studies Guide
Learn bracketing and matrixing in stability studies, ICH Q1D requirements, protocol design, regulatory expectations, and practical examples. Definition Bracketing and matrixing are reduced stability testing designs described in ICH Q1D that minimize the number of stability samples tested while maintaining scientific confidence in shelf-life determination. Bracketing evaluates only extreme configurations, while matrixing tests selected subsets…
-
ICH Q1A(R2) Stability Guidelines
Learn ICH Q1A(R2) stability guidelines, testing conditions, batch requirements, shelf-life determination, and GMP compliance for pharmaceuticals. Definition ICH Q1A(R2) is the internationally harmonized guideline that defines stability testing requirements for new drug substances and products. It establishes standard storage conditions, testing durations, and data requirements used to determine retest periods, shelf life, and storage recommendations…
FAQ’s
have any questions for us?
Pharma Documentation Simplified.
1. What is pharmaceutical documentation?
Pharmaceutical documentation is the systematic recording of processes, procedures, tests, and controls involved in the manufacturing, quality assurance, and distribution of pharmaceutical products. It ensures product quality, safety, traceability, and regulatory compliance.
2. Why is documentation important in the pharmaceutical industry?
Documentation is critical to ensure:
• Compliance with regulatory requirements (GMP, DRAP, FDA, WHO, USP, BP)
• Product quality and patient safety
• Traceability and accountability
• Data integrity and audit readines
3. What types of pharmaceutical documents are commonly used?
Common pharmaceutical documents include:
• Standard Operating Procedures (SOPs)
• Batch Manufacturing Records (BMR)
• Batch Packaging Records (BPR)
• Master Formula Records (MFR)
• Validation protocols and reports
• Quality control and stability reports
• Change control and deviation records
4. What are Good Documentation Practices (GDP)?
Good Documentation Practices (GDP) are guidelines that ensure documents are:
GDP helps maintain data integrity and regulatory compliance.
Accurate, clear, and legible
Written in real time
Properly signed and dated
Secure and traceable
5. Who is responsible for maintaining pharmaceutical documentation?
All personnel involved in pharmaceutical operations share responsibility for accurate documentation. However, Quality Assurance (QA) is primarily responsible for document approval, control, revision, and archiving.
6. What are common documentation errors to avoid?
Common errors include:
* Incomplete or inconsistent records
* Missing signatures or dates
* Overwriting or use of correction fluid
* Backdating entries
* Illegible handwriting
7. What regulations govern pharmaceutical documentation?
Pharmaceutical documentation is governed by:
* USP, BP, and IP standards
* WHO-GMP guidelines
* FDA 21 CFR Parts 210, 211, and 11
* MHRA Act & Rules
* ICH guidelines
8. How can documentation quality be improved?
Documentation quality can be improved by:
* Regular staff training
* Standardized templates
* Routine audits and reviews
* Clear SOPs and GDP enforcement
* Use of digital documentation systems